[go: up one dir, main page]

PL346768A1 - Dry powder active agent pulmonary delivery - Google Patents

Dry powder active agent pulmonary delivery

Info

Publication number
PL346768A1
PL346768A1 PL99346768A PL34676899A PL346768A1 PL 346768 A1 PL346768 A1 PL 346768A1 PL 99346768 A PL99346768 A PL 99346768A PL 34676899 A PL34676899 A PL 34676899A PL 346768 A1 PL346768 A1 PL 346768A1
Authority
PL
Poland
Prior art keywords
active agent
dry powder
pulmonary delivery
powder active
agent pulmonary
Prior art date
Application number
PL99346768A
Other versions
PL195574B1 (en
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of PL346768A1 publication Critical patent/PL346768A1/en
Publication of PL195574B1 publication Critical patent/PL195574B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL99346768A 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery PL195574B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
PL346768A1 true PL346768A1 (en) 2002-02-25
PL195574B1 PL195574B1 (en) 2007-10-31

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99346768A PL195574B1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CN1198593C (en) 1999-06-09 2005-04-27 罗伯特·E·希弗斯 Supercritical Fluid Assisted Spray and Bubble Drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
PT1455755E (en) 2001-11-20 2013-06-18 Civitas Therapeutics Inc Improved particulate compositions for pulmonary delivery
EP1487774B1 (en) 2002-02-25 2018-09-19 Diffusion Pharmaceuticals LLC Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
EP1575563B1 (en) * 2002-12-19 2007-02-14 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
EP2708225B1 (en) 2004-04-23 2018-12-26 CyDex Pharmaceuticals, Inc. DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
JP2008531582A (en) * 2005-02-24 2008-08-14 ディフュージョン・ファーマシューティカルズ・エルエルシー Trans carotenoids, their synthesis, formulation and use
AU2006221364A1 (en) * 2005-03-09 2006-09-14 Ono Pharmaceutical Co., Ltd. Particle and preparation containing the particle
KR101152886B1 (en) 2005-10-26 2012-07-09 사이덱스 파마슈티칼스, 인크. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (en) * 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Anti-caking granular formulation
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
US8293804B2 (en) 2007-04-13 2012-10-23 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
WO2009058399A1 (en) 2007-10-31 2009-05-07 Diffusion Pharmaceuticals Llc A new class of therapeutics that enhance small molecule diffusion
CN102481356A (en) 2009-05-20 2012-05-30 Aeras全球Tb疫苗基金会 Stable spray-dried immunogenic viral compositions
EP3539542B1 (en) 2009-06-22 2023-04-19 Diffusion Pharmaceuticals LLC Diffusion enhancing compounds and their use with a thrombolytic
AU2011262361A1 (en) 2010-06-02 2013-01-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
RU2650636C2 (en) * 2012-05-03 2018-04-16 Янссен Сайенсиз Айрлэнд Юси Polyinosinic-polycytidylic acid (poly(i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (en) 2014-10-31 2020-12-21 Univ Monash POWDER FORMULATION
KR102489034B1 (en) 2016-03-24 2023-01-13 디퓨젼 파마슈티컬즈 엘엘씨 Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
EP0611567B1 (en) * 1992-06-12 2002-08-28 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
ATE287257T1 (en) * 1997-01-16 2005-02-15 Massachusetts Inst Technology PREPARATION OF PARTICLE-CONTAINING MEDICINAL PRODUCTS FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
TR200101182T2 (en) 2001-09-21
SK3442001A3 (en) 2001-11-06
AP2001002093A0 (en) 2001-03-31
NZ510168A (en) 2003-09-26
KR20010075063A (en) 2001-08-09
PL195574B1 (en) 2007-10-31
AP1374A (en) 2005-02-28
HN1999000159A (en) 1999-11-11
SA99200718B1 (en) 2006-11-04
EE200100151A (en) 2002-06-17
IS5878A (en) 2001-03-05
CA2343920A1 (en) 2000-03-23
UA76085C2 (en) 2006-07-17
NO20011251L (en) 2001-04-17
WO2000015262A1 (en) 2000-03-23
ZA200101995B (en) 2002-03-11
NO20011251D0 (en) 2001-03-13
JP2002524535A (en) 2002-08-06
PE20001061A1 (en) 2000-10-08
EP1117442A1 (en) 2001-07-25
ID28845A (en) 2001-07-05
PA8481901A1 (en) 2002-04-25
EA200100300A1 (en) 2001-10-22
LV12658B (en) 2001-09-20
CN1317977A (en) 2001-10-17
IL141562A0 (en) 2002-03-10
BR9913722A (en) 2001-05-29
CO5130023A1 (en) 2002-02-27
BG105430A (en) 2001-12-29
MA25590A1 (en) 2002-12-31
YU24201A (en) 2003-08-29
HRP20010189A2 (en) 2005-04-30
CZ2001829A3 (en) 2001-09-12
AR022090A1 (en) 2002-09-04
GT199900156A (en) 2001-03-07
HUP0103837A3 (en) 2002-11-28
TNSN99173A1 (en) 2005-11-10
HUP0103837A2 (en) 2002-05-29
DZ2892A1 (en) 2003-12-15
UY25711A1 (en) 1999-11-17
HK1042231A1 (en) 2002-08-09
LV12658A (en) 2001-05-20
EA003476B1 (en) 2003-06-26
LT2001021A (en) 2001-11-26
AU753014B2 (en) 2002-10-03
LT4897B (en) 2002-02-25
OA11781A (en) 2005-07-26
MY129282A (en) 2007-03-30
TWI226248B (en) 2005-01-11
AU6039799A (en) 2000-04-03
IL141562A (en) 2007-07-24
GEP20043257B (en) 2004-06-25

Similar Documents

Publication Publication Date Title
AP2001002093A0 (en) Dry powder active agent pulmonary delivery
EP0927025A4 (en) Liposome encapsulated active agent dry powder composition
HUP0001799A3 (en) Dry powder inhaler
HUP0100848A3 (en) Aerosolized active agent delivery
EP1307256A4 (en) Dry powder inhaler
SI1294421T1 (en) Dry Powder Inhaler
HUP9903819A3 (en) Dry powder inhaler
PL360118A1 (en) Continuous dry powder inhaler
IL137472A0 (en) Microparticle inhalation formulations
IL149362A0 (en) Aerosol composition comprising formoterol
DE60035911D1 (en) dry powder inhaler
HUP0104483A3 (en) Fungicidal active substance combinations and use thereof
HUT74899A (en) Dry powder inhaler
SI1397174T1 (en) Powder formulation disintegrating system and dry powder inhalers
HUP0203400A3 (en) Synergestic herbicidal composition, preparation and use thereof
PL341820A1 (en) Coating composition in the form of dry powder
GB9916316D0 (en) Dry powder compositions
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
GB9719093D0 (en) Improvements to dry powder inhalers
GB0003935D0 (en) Formulation for dry powder inhaler
CZ20021359A3 (en) Preparation for fighting dry rots
AU1752601A (en) Dry powder inhaler
HUP0105425A3 (en) Suspo-emulsion formulation
GB0028828D0 (en) Improved pesticide formulation
HK1036941A (en) Pulmonary delivery of active agents

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20070913